Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of cabozantinib and atezolizumab to treat cancer

Combinations of cabozantinib and atezolizumab to treat cancer

US Patent 11198731 · Granted Dec 14, 2021

Estimated economic value: $55,483,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Liquid dosage forms to treat cancer2024
Liquid dosage forms to treat cancer2022
Method of treating cancer and bone cancer pain2022
Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-ylox2021
Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-ylox2021
Method of treating renal cell carcinoma using N-(4-(6,7-dimethoxyquinolin-4-ylox2021
Antimicrobial compound2020
Synthesis of silicon nanorods2014
Method for preparing nanocrystalline silicon in SiO2 and freestanding silicon na2012
Method for predicting response to epidermal growth factor receptor-directed ther2010